UKONIQ-UMBRALISIB INSTRUCTIONS
Ukoniq (umbralisib) indications
UKONIQ is a kinase inhibitor indicated for adult patients with:
• Relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based therapy.
• Relapsed or refractory follicular lymphoma (FL) who have received at least three prior systemic therapies.
Let us work together to protect precious health